Jennifer Baldock - Surgery Partners Senior Vice President General Counsel, Secretary
| SGRY Stock | USD 23.60 0.19 0.81% |
President
Ms. Jennifer Boyd Baldock is a Executive Vice President, Chief Legal Officer of Surgery Partners, Inc. since May 2018. Previously, Ms. Baldock served as our Senior Vice President, Secretary and General Counsel of Surgery Center Holdings, Inc. since our acquisition of Symbion Holdings Corporation in November 2014 and as Vice President, Secretary and General Counsel of Surgery Partners, Inc. since April 2015. In addition, Ms. Baldock previously served as General Counsel and Chief Compliance Officer of Symbion Holdings Corporation and Symbion, Inc. Prior to joining Symbion in 2010, she served as Assistant General Counsel for both Ambulatory Services of America and Renal Care Group. Prior to that, Ms. Baldock practiced law with Waller Lansden Dortch and Davis in Nashville, Tennessee, concentrating in corporate law with an emphasis on healthcare mergers and acquisitions. She is also a Certified Public Accountant since 2018.
| Age | 53 |
| Tenure | 6 years |
| Address | 340 Seven Springs Way, Brentwood, TN, United States, 37027 |
| Phone | 615 234 5900 |
| Web | https://www.surgerypartners.com |
Surgery Partners Management Efficiency
The company has return on total asset (ROA) of 0.039 % which means that it generated a profit of $0.039 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0308 %, meaning that it created $0.0308 on every $100 dollars invested by stockholders. Surgery Partners' management efficiency ratios could be used to measure how well Surgery Partners manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to rise to 0.07 in 2024, whereas Return On Tangible Assets are likely to drop (0.01) in 2024. At this time, Surgery Partners' Intangibles To Total Assets are fairly stable compared to the past year. Debt To Assets is likely to rise to 0.59 in 2024, whereas Total Assets are likely to drop slightly above 4.6 B in 2024.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Sean Gaffney | Addus HomeCare | 44 | |
| Jerry Gray | Encompass Health Corp | N/A | |
| Leroy McIntosh | National HealthCare | 63 | |
| Spencer Burton | The Ensign Group | 45 | |
| Peter Mantegazza | Encompass Health Corp | N/A | |
| Patrick Darby | Encompass Health Corp | 56 | |
| Michael Ussery | National HealthCare | 65 | |
| Frank Brown | Encompass Health Corp | N/A | |
| Bryan McCartney | Healthcare Services Group | 63 | |
| Thomas Mullin | Select Medical Holdings | 40 | |
| Jeffrey Smith | National HealthCare | 61 | |
| Zheng Cheng | Concord Medical Services | 57 | |
| Brian Kidd | National HealthCare | 49 | |
| John Saich | Select Medical Holdings | 55 | |
| Barbara Jacobsmeyer | Encompass Health Corp | 55 | |
| R Ussery | National HealthCare | 60 | |
| Michael Scarbrough | InnovAge Holding Corp | N/A | |
| Marc Miller | Universal Health Services | 53 | |
| Brian Poff | Addus HomeCare | 50 | |
| Linda Wilder | Encompass Health Corp | N/A | |
| Kevin Reese | The Ensign Group | N/A | |
Management Performance
| Return On Equity | 0.0308 | ||||
| Return On Asset | 0.039 |
Surgery Partners Leadership Team
Elected by the shareholders, the Surgery Partners' board of directors comprises two types of representatives: Surgery Partners inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Surgery. The board's role is to monitor Surgery Partners' management team and ensure that shareholders' interests are well served. Surgery Partners' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Surgery Partners' outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Doherty, Executive CFO | ||
| Bradley Owens, President Group | ||
| Danielle Burkhalter, Executive Officer | ||
| Jennifer JD, Executive Officer | ||
| Harrison Bane, President Group | ||
| Jennifer Baldock, Senior Vice President General Counsel, Secretary | ||
| Wayne DeVeydt, Executive Chairman | ||
| David CPA, Executive CFO | ||
| Roxanne Womack, Senior Officer | ||
| Spencer Clark, General VP | ||
| Neil Zieselman, Senior Controller | ||
| Eric Evans, COO, Executive Vice President | ||
| Kristi Jensen, Senior Region | ||
| Marissa Brittenham, Executive Officer | ||
| Varun Gadhok, Senior Officer | ||
| Anthony Taparo, President - Atlantic Group |
Surgery Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Surgery Partners a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0308 | ||||
| Return On Asset | 0.039 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 6.27 B | ||||
| Shares Outstanding | 127.11 M | ||||
| Shares Owned By Insiders | 1.12 % | ||||
| Shares Owned By Institutions | 98.88 % | ||||
| Number Of Shares Shorted | 10.07 M | ||||
| Price To Earning | 61.84 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Surgery Stock Analysis
When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.